Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study

QR Code

Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study

Bibliographic Details
Main Authors:	Hyams, D., Chan, Arlene, de Oliveira, C., Snyder, R., Vinholes, J., Audeh, M W., Alencar, V., Lombard, J., Mookerjee, B., Xu, J., Brown, K., Klein, P.
Format:	Journal Article
Published:	Springer Science + Business Media 2013
Online Access:	http://hdl.handle.net/20.500.11937/33934

Similar Items

Fulvestrant for the treatment of advanced breast cancer
by: Blackburn, Sophie A., et al.
Published: (2018)

Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer
by: Robertson, John F.R., et al.
Published: (2018)

Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009)

TILs in metastatic breast cancer—no surprises, but more questions
by: Chan, Arlene
Published: (2017)

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
by: Robertson, John F.R., et al.
Published: (2017)

HER2 positive metastatic breast cancer: What happens after first line failure?
by: Chan, Arlene
Published: (2016)

Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
by: Backen, Alison C., et al.
Published: (2018)

Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2010)

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
by: Valle, Juan W., et al.
Published: (2015)

A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
by: Chan, Arlene, et al.
Published: (2012)

An investigation of metastatic colorectal cancer
by: Asiri, Abutaleb
Published: (2018)

Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome
by: Cadagan, David, et al.
Published: (2016)

Immobilization and characterization of hormone-sensitive lipase (HSL) from Glaciozyma antarctica
by: Ishak, Siti Nor Hasmah, et al.
Published: (2024)

An investigation of metastatic markers in models of paediatric medulloblastoma
by: Nasir, Aishah
Published: (2017)

Investigating the role of Cten in metastatic colorectal cancer
by: Thorpe, Hannah
Published: (2016)

Metastatic adenocarcinoma of the lung mimicking spinal tuberculosis
by: Zakaria@Mohamad, Zamzuri, et al.
Published: (2011)

RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
by: Baselga, J., et al.
Published: (2017)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
by: De Boer, R., et al.
Published: (2012)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2013)

Growth hormone and physical exercise: Current considerations
by: Cruzat, Vinicius, et al.
Published: (2008)

Optimising targeted antibodies for the treatment of metastatic solid tumours
by: Herbertson, Rebecca A.
Published: (2009)

Investigation the role of CD24 in metastatic colorectal cancer
by: Alsulaiman, Abdullah
Published: (2018)

Molecular characterisation of the early metastatic phenotype in colorectal cancer
by: Sculthorpe, Declan
Published: (2024)

Metastatic thyroid carcinoma presenting with spinal cord compression.
by: Hassan, H. A., et al.
Published: (2010)

Metastatic adenocarcinoma of temporal bone with collet-sicard syndrome
by: Subha, Sethu Thakachy, et al.
Published: (2018)

The current status of checkpoint inhibitors in metastatic bladder cancer
by: Fahmy Ahmed, Omar Ahmed, et al.
Published: (2016)

Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
by: Dent, R., et al.
Published: (2013)

Study investigating the role of skeletal muscle mass estimation in metastatic spinal cord compression
by: Gakhar, H., et al.
Published: (2015)

Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2014)

Pigment epithelium-derived factor and menopause in metastatic breast cancer
by: Brook, Naomi Louise
Published: (2022)

Evaluation of prognostic factors and survival of patients with metastatic bone disease
by: Abumarzouq, Mahmoud F. R.
Published: (2016)

Growth Hormone increases gonadotropin receptors in poor-prognosis patients
by: Regan, S., et al.
Published: (2012)

Motivational determinants of dancer’s health-related immunological and hormonal responses
by: Quested, Eleanor, et al.
Published: (2012)

Identification of drought responsive Elaeis guineensis WRKY transcription factors with sensitivity to other abiotic stresses and hormone treatments
by: Lee, Fong Chin, et al.
Published: (2022)

DEAD-box helicase DP103 defines metastatic potential of human breast cancers
by: Shin, E., et al.
Published: (2014)

Cystic meningioma masquerading as a metastatic tumor: A case report
by: Ramanathan, Nithya, et al.
Published: (2016)

CT features of metastatic linitis plastica of the rectum - a case report
by: Che Aun, Azlida, et al.
Published: (2012)

Effect of deep diaphragmatic breathing on pain in patients with metastatic gastrointestinal cancers
by: Rezaei, Maryam, et al.
Published: (2024)

Evaluation of fatty liver in breast cancer patients and its metastatic potential
by: Ahmad, Nor Hayati
Published: (2021)

Expression, characterisation and homology modelling of a novel hormone-sensitive lipase (HSL)-like esterase from Glaciozyma antarctica
by: Mohamad Tahir, Hiryahafira, et al.
Published: (2020)